TFF Pharmaceuticals
Ejecutivos
Ver el organigrama con sus 11 ejecutivos principales
Biografías más buscadas en TFF Pharmaceuticals
- Harlan Weisman, Vice Chairman of the Board and Chief Executive Off...
- Stephen Rocamboli, Director
- Robert Mills, Director
Recientes movimientos de ejecutivos en TFF Pharmaceuticals
- Thomas King, se ha incorporado a la empresa como Director (noticia publicada el 14 de diciembre de 2023).
- Catherine Lee, se ha incorporado a la empresa como Director (noticia publicada el 1 de diciembre de 2023).
Crear su alerta
para seguir los movimientos de los ejecutivos en TFF Pharmaceuticals.
Farmacia
TFF Pharmaceuticals tiene 1.863 competidores entre los que se incluyen Pfizer (Estados Unidos), Sanofi (Francia) y Johnson & Johnson (Estados Unidos).
Popular M&A news in Farmacia
- AstraZeneca has announced the acquisition of Fusion Pharma (publicado el 23 de marzo de 2024).
- AstraZeneca has announced the acquisition of Amolyt Pharma (publicado el 19 de marzo de 2024).
- Frontier Medicines acaba de anunciar una recaudación de fondos de 80 millones de dólares. (publicado el 27 de febrero de 2024).
Otros contactos sugeridos en el sector Farmacia
Noticias
Últimos comunicados de prensa de TFF Pharmaceuticals
- TFF Pharmaceuticals Announces Oral Presentation of Interim Data from the Phase 2 Study of Tacrolimus Inhalation Powder (TFF TAC) for the Prevention of Lung Transplant Rejection at the 44th Annual International Society for Heart and Lung Transplantation (I
- TFF Pharmaceuticals Reports Fourth Quarter and Full Year 2023 Financial Results | TFF Pharmaceuticals
- TFF Pharmaceuticals Announces Updated Data from the Tacrolimus Inhalation Powder (TFF TAC) and Voriconazole Inhalation Powder (TFF VORI) Clinical Programs | TFF Pharmaceuticals
- TFF Pharmaceuticals Announces Closing of $1.2 Million Registered Direct Offering Priced At-The-Market Under Nasdaq Rules | TFF Pharmaceuticals
- TFF Pharmaceuticals Announces Update on Clinical Programs | TFF Pharmaceuticals
- TFF Pharmaceuticals Announces $1.2 Million Registered Direct Offering Priced At-The-Market Under Nasdaq Rules | TFF Pharmaceuticals
- TFF Pharmaceuticals to Participate in the 36th Annual Roth Conference – March 17-19, 2024 | TFF Pharmaceuticals
- TFF Pharmaceuticals to Present Data from Phase 2 Trial of Voriconazole Inhalation Powder (TFF VORI) for the Treatment of Invasive Pulmonary Aspergillosis at the 11th Advances Against Aspergillosis & Mucormycosis Conference | TFF Pharmaceuticals
- TFF Pharmaceuticals Announces Acceptance of Late-Breaking Abstract for Presentation at the 44th Annual International Society for Heart and Lung Transplantation (ISHLT) 2024 Meeting | TFF Pharmaceuticals
- TFF Pharmaceuticals to Host Webcast and Conference to Review Initial Data from the Ongoing Phase 2 Trials of TFF VORI and TFF TAC | TFF Pharmaceuticals
- View more press releases Close
Redes sociales sobre TFF Pharmaceuticals
- TFF Pharmaceuticals en Wikipedia, Google News y Yahoo Finance
- TFF Pharmaceuticals en LinkedIn, Twitter y YouTube
Ponerse en contacto
Contactar a través de e-mail con sus ejecutivos Harlan Weisman 
Llame a TFF Pharmaceuticals al +1 737...
